vs

Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and Upstart Holdings, Inc. (UPST). Click either name above to swap in a different company.

Upstart Holdings, Inc. is the larger business by last-quarter revenue ($296.1M vs $164.7M, roughly 1.8× PTC THERAPEUTICS, INC.). Upstart Holdings, Inc. runs the higher net margin — 6.3% vs -82.0%, a 88.3% gap on every dollar of revenue. On growth, Upstart Holdings, Inc. posted the faster year-over-year revenue change (35.2% vs -22.7%). Upstart Holdings, Inc. produced more free cash flow last quarter ($108.4M vs $-36.6M). Over the past eight quarters, Upstart Holdings, Inc.'s revenue compounded faster (52.2% CAGR vs -11.5%).

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

Upstart is an AI lending platform that partners with banks and credit unions to provide consumer loans using non-traditional variables, such as education and employment, to predict creditworthiness.

PTCT vs UPST — Head-to-Head

Bigger by revenue
UPST
UPST
1.8× larger
UPST
$296.1M
$164.7M
PTCT
Growing faster (revenue YoY)
UPST
UPST
+58.0% gap
UPST
35.2%
-22.7%
PTCT
Higher net margin
UPST
UPST
88.3% more per $
UPST
6.3%
-82.0%
PTCT
More free cash flow
UPST
UPST
$145.0M more FCF
UPST
$108.4M
$-36.6M
PTCT
Faster 2-yr revenue CAGR
UPST
UPST
Annualised
UPST
52.2%
-11.5%
PTCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PTCT
PTCT
UPST
UPST
Revenue
$164.7M
$296.1M
Net Profit
$-135.0M
$18.6M
Gross Margin
Operating Margin
-43.3%
6.4%
Net Margin
-82.0%
6.3%
Revenue YoY
-22.7%
35.2%
Net Profit YoY
-104.8%
776.4%
EPS (diluted)
$-1.63
$0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PTCT
PTCT
UPST
UPST
Q4 25
$164.7M
$296.1M
Q3 25
$211.0M
$277.1M
Q2 25
$178.9M
$257.3M
Q1 25
$1.2B
$213.4M
Q4 24
$213.2M
$219.0M
Q3 24
$196.8M
$162.1M
Q2 24
$186.7M
$127.6M
Q1 24
$210.1M
$127.8M
Net Profit
PTCT
PTCT
UPST
UPST
Q4 25
$-135.0M
$18.6M
Q3 25
$15.9M
$31.8M
Q2 25
$-64.8M
$5.6M
Q1 25
$866.6M
$-2.4M
Q4 24
$-65.9M
$-2.8M
Q3 24
$-106.7M
$-6.8M
Q2 24
$-99.2M
$-54.5M
Q1 24
$-91.6M
$-64.6M
Operating Margin
PTCT
PTCT
UPST
UPST
Q4 25
-43.3%
6.4%
Q3 25
1.4%
8.5%
Q2 25
-19.5%
1.8%
Q1 25
82.5%
-2.1%
Q4 24
-76.2%
-2.2%
Q3 24
-27.7%
-27.8%
Q2 24
-21.5%
-43.5%
Q1 24
-21.6%
-52.8%
Net Margin
PTCT
PTCT
UPST
UPST
Q4 25
-82.0%
6.3%
Q3 25
7.5%
11.5%
Q2 25
-36.3%
2.2%
Q1 25
73.7%
-1.1%
Q4 24
-30.9%
-1.3%
Q3 24
-54.2%
-4.2%
Q2 24
-53.1%
-42.7%
Q1 24
-43.6%
-50.5%
EPS (diluted)
PTCT
PTCT
UPST
UPST
Q4 25
$-1.63
$0.20
Q3 25
$0.20
$0.23
Q2 25
$-0.83
$0.05
Q1 25
$10.04
$-0.03
Q4 24
$-0.85
$-0.01
Q3 24
$-1.39
$-0.07
Q2 24
$-1.29
$-0.62
Q1 24
$-1.20
$-0.74

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PTCT
PTCT
UPST
UPST
Cash + ST InvestmentsLiquidity on hand
$1.9B
$652.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$-205.3M
$798.8M
Total Assets
$2.9B
$3.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PTCT
PTCT
UPST
UPST
Q4 25
$1.9B
$652.4M
Q3 25
$1.7B
$489.8M
Q2 25
$2.0B
$395.9M
Q1 25
$2.0B
$599.8M
Q4 24
$1.1B
$788.4M
Q3 24
$1.0B
Q2 24
$1.1B
Q1 24
$884.8M
Stockholders' Equity
PTCT
PTCT
UPST
UPST
Q4 25
$-205.3M
$798.8M
Q3 25
$-155.8M
$743.7M
Q2 25
$-206.5M
$722.0M
Q1 25
$-185.8M
$676.6M
Q4 24
$-1.1B
$633.2M
Q3 24
$-1.1B
$595.5M
Q2 24
$-980.2M
$594.7M
Q1 24
$-893.9M
$612.8M
Total Assets
PTCT
PTCT
UPST
UPST
Q4 25
$2.9B
$3.0B
Q3 25
$2.6B
$2.9B
Q2 25
$2.6B
$2.5B
Q1 25
$2.7B
$2.3B
Q4 24
$1.7B
$2.4B
Q3 24
$1.8B
$1.8B
Q2 24
$1.9B
$1.8B
Q1 24
$1.8B
$1.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PTCT
PTCT
UPST
UPST
Operating Cash FlowLast quarter
$-34.3M
$108.6M
Free Cash FlowOCF − Capex
$-36.6M
$108.4M
FCF MarginFCF / Revenue
-22.3%
36.6%
Capex IntensityCapex / Revenue
1.4%
0.1%
Cash ConversionOCF / Net Profit
5.82×
TTM Free Cash FlowTrailing 4 quarters
$702.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PTCT
PTCT
UPST
UPST
Q4 25
$-34.3M
$108.6M
Q3 25
$-66.3M
$-122.6M
Q2 25
$-58.3M
$-120.2M
Q1 25
$870.1M
$-13.5M
Q4 24
$-30.0M
$-110.9M
Q3 24
$-77.0M
$179.3M
Q2 24
$-71.5M
$65.3M
Q1 24
$70.8M
$52.6M
Free Cash Flow
PTCT
PTCT
UPST
UPST
Q4 25
$-36.6M
$108.4M
Q3 25
$-69.7M
$-122.7M
Q2 25
$-59.6M
$-120.3M
Q1 25
$868.4M
Q4 24
$-33.8M
Q3 24
$-77.5M
$179.2M
Q2 24
$-78.8M
$65.3M
Q1 24
$61.2M
$51.9M
FCF Margin
PTCT
PTCT
UPST
UPST
Q4 25
-22.3%
36.6%
Q3 25
-33.1%
-44.3%
Q2 25
-33.3%
-46.7%
Q1 25
73.8%
Q4 24
-15.8%
Q3 24
-39.4%
110.5%
Q2 24
-42.2%
51.1%
Q1 24
29.1%
40.6%
Capex Intensity
PTCT
PTCT
UPST
UPST
Q4 25
1.4%
0.1%
Q3 25
1.6%
0.0%
Q2 25
0.7%
0.0%
Q1 25
0.1%
0.0%
Q4 24
1.8%
0.0%
Q3 24
0.3%
0.1%
Q2 24
4.0%
0.0%
Q1 24
4.6%
0.5%
Cash Conversion
PTCT
PTCT
UPST
UPST
Q4 25
5.82×
Q3 25
-4.17×
-3.86×
Q2 25
-21.43×
Q1 25
1.00×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PTCT
PTCT

Segment breakdown not available.

UPST
UPST

Personal Lending Segment$201.4M68%
Servicing Fees Net$39.5M13%
Servicing Fees$27.5M9%
Other$15.7M5%
Borrower Fees$8.4M3%
Collection Agency Fees$3.5M1%

Related Comparisons